Search

Current filters: HIV drugs, HIV, English

Dolutegravir and TAF or TDF—safety issues and weight gain

From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage

From wasting to obesity—the changing issue of weight in HIV

From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage

Fostemsavir compassionate access program

From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage

Fostemsavir in treatment-experienced people

From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage

The debut of fostemsavir

From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage

Doravirine begins to be listed on formularies

From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage

Decreasing the risk of neural tube defects with dolutegravir

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Some issues to consider with Dovato (dolutegravir + 3TC)

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Dovato (dolutegravir + 3TC) in initial HIV treatment

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage